17758 Federal Register / Vol. 80, No. 63 / Thursday, April 2, 2015 / Notices 

Biomedical Engineering Society (BMES) 

is announcing a public conference 

entitled ‘‘Frontiers in Medical Devices: 

Innovations in Modeling and 

Simulation’’. The purpose of this 

conference is to provide a forum to 

discuss strategies to effectively utilize 

computational modeling and simulation 

in the development and evaluation of 

medical devices. 

Date and Time: The conference will 

be held on May 18 through 20, 2015, 

from 8 a.m. to 6 p.m. 

Location: The public conference will 

be held at the Marriott Inn and 

Conference Center, University of 

Maryland, 3501 University Blvd. East, 

Hyattsville, MD 20783. 

Contact Person: Donna R. Lochner, 

Center for Devices and Radiological 

Health, Food and Drug Administration, 

10903 New Hampshire Ave., Bldg. 62, 

Rm. 3220, Silver Spring, MD 20993, 

301–796–6309, Donna.Lochner@

fda.hhs.gov. 

Registration: To register for the public 

conference please visit FDA’s Medical 

Devices News, Events, Workshops, and 

Conferences calendar at http://

www.bmes.org/meddevicesconference. 

There is a registration fee to attend the 

public conference to cover the expenses, 

and attendees must register in advance. 

The fees vary depending upon 

membership status in BMES, and 

include BMES members ($450), nonBMES members (includes 1 year BMES 

membership) ($600), and Government 

rate (BMES memberships and meals are 

not included) ($250). Students will be 

offered a discounted fee of $300 (BMES 

member) or $350 (non-BMES member) 

(includes 1 year BMES membership). A 

full listing of the registration fees can be 

found on the Web site listed. Although 

the facilities are spacious, registration 

will be on a first-come, first-served 

basis. 

If you need special accommodations 

due to a disability, please contact Betse 

Lyons at Betse@bmes.org or 301–459– 

1999, 8201 Corporate Drive, Suite 1125, 

Landover, MD 20785–2224, FAX: 301– 

459–2444, no later than May 4, 2015. 

To register for the public conference, 

please visit BMES Frontiers in Medical 

Devices registration page at http://

bmes.org/meddevicesregistration. Those 

without Internet access should contact 

Betse Lyons at 301–459–1999 to register. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Center for Devices and 

Radiological Health (CDRH) believes 

that computer modeling and simulation 

(M&S) has the potential to substantially 

augment traditional models used to 

evaluate medical devices; i.e., animal, 

bench, and human models, and to 

accelerate and streamline the total 

product life cycle of a medical device. 

The use of computer models to simulate 

multiple use conditions and to visualize 

and display complex processes and data 

can revolutionize the way medical 

outcomes and medical devices are 

understood. Non-proprietary computer 

models could benchmark device 

performance, yet lack of access to 

biomedical data to construct the models 

and rigorous methods to validate the 

models limit their credibility and use. 

To foster good science for M&S in the 

medical device community, CDRH 

needs to leverage the expertise in 

industry and academia to advance M&S 

for regulatory uses. 

II. Topics for Discussion at the Public 

Workshop 

A large number of issues will be 

discussed at the conference with the 

overall theme being the application of 

modeling and simulation for medical 

devices at different stages in the total 

product life cycle. Topics include, but 

are not limited to the following: 

• Model foundations for device 

design ideation; 

• concept development and design 

optimization; 

• modeling for robust design; 

• design verification and validation; 

• patient specific design; 

• integration of modeling with 

clinical studies; 

• modeling and device 

commercialization. 

This public workshop may also form 

the basis for future discussions related 

to computer modeling and simulation 

that could benefit U.S. public health. 

Dated: March 27, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–07551 Filed 4–1–15; 8:45 am] 

BILLING CODE CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute Of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Mentoring Programs for HIV/AIDS 

Researchers 2. 

Date: March 30, 2015. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Aileen Schulte, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1225, 

aschulte@mail.nih.gov 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: March 27, 2015. 

Carolyn A. Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–07507 Filed 4–1–15; 8:45 am] 

BILLING CODE CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0481] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; New Animal Drugs 

for Investigational Uses 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 


tkelley on DSK3SPTVN1PROD with NOTICES